Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - Insys Therapeutics, Inc. | insy20130930_10q.htm |
| EX-31 - EXHIBIT 31.2 - Insys Therapeutics, Inc. | ex31-2.htm |
| EX-32 - EXHIBIT 32.1 - Insys Therapeutics, Inc. | ex32-1.htm |
| EX-31 - EXHIBIT 31.1 - Insys Therapeutics, Inc. | ex31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Insys Therapeutics, Inc. | Financial_Report.xls |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Insys Therapeutics, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Periodic Report”), I, Darryl S. Baker, Chief Financial Officer of the Company, certify, to my knowledge that:
(1) The Periodic Report, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
By: |
/s/ Darryl S. Baker |
| ||
|
|
Name: |
Darryl S. Baker |
| |
|
|
Title: |
Chief Financial Officer |
| |
|
|
|
| ||
|
Date: November 12, 2013 |
|
|||